Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin for hyperphosphatemia in chronic kidney disease
PACTR201905507865682Phase 2Recruiting
- Sponsor
- Edema Oritseweyinmi Great
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of niacin in hyperphosphatemia and chronic kidney disease (CKD) (2 arms), sponsored by Edema Oritseweyinmi Great. Primary endpoint: Mean change in serum phosphate levels from first to last week. Started Apr 2019; status: recruiting.
02
Drugs
niacin
03
Conditions
hyperphosphatemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on PACTR201905507865682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201905507865682.